Molecule Details
InChIKeyBXHKUQJOWIKKIH-LNDVOCBLSA-N
Compound Name[(3aR,4S,6aR)-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]furan-4-yl] N-[(1S,2R)-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-1-benzyl-2-hydroxy-propyl]carbamate
Canonical SMILESCC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CC[C@H]2OCC[C@@H]12
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Homologous
Avg pChEMBL7.77
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
P12497 gag-pol Human immunodeficiency virus type 1 group M subtype B (isolate NY5) Pathogen PF00540 PF19317 PF00552 PF02022 PF00075 PF00665 PF00077 PF00078 PF06815 PF06817 PF00098 7.8 IC50 BindingDB
Q72874 pol Human immunodeficiency virus type 1 Pathogen PF00077 7.8 IC50 ChEMBL
Q9YQ12 protease Human immunodeficiency virus type 1 Pathogen PF00077 7.8 IC50 ChEMBL